Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyBiologicalProcessregulation of response to osmotic stress

GYPA GYPB GYPE

2.93e-0621283GO:0047484
GeneOntologyBiologicalProcessresponse to osmotic stress

GYPA PDPK1 GYPB GYPE

1.58e-05113284GO:0006970
GeneOntologyBiologicalProcessregulation of cardiac muscle cell apoptotic process

GATA4 FNDC1 PDPK1

1.98e-0484283GO:0010665
GeneOntologyBiologicalProcessregulation of striated muscle cell apoptotic process

GATA4 FNDC1 PDPK1

2.28e-0488283GO:0010662
GeneOntologyBiologicalProcesscardiac muscle cell apoptotic process

GATA4 FNDC1 PDPK1

2.43e-0490283GO:0010659
GeneOntologyBiologicalProcessstriated muscle cell apoptotic process

GATA4 FNDC1 PDPK1

2.76e-0494283GO:0010658
GeneOntologyCellularComponentankyrin-1 complex

GYPA GYPB GYPE

2.86e-0710293GO:0170014
GeneOntologyCellularComponentGolgi lumen

MUC16 SDC3 MUC5B

4.57e-04109293GO:0005796
GeneOntologyCellularComponentexternal side of plasma membrane

MUC16 TMEM123 GYPA GYPB GYPE

6.71e-04519295GO:0009897
GeneOntologyCellularComponentside of membrane

MUC16 TMEM123 FRMD6 GYPA GYPB GYPE

1.10e-03875296GO:0098552
HumanPhenoTesticular gonadoblastoma

GATA4 MAP3K1

1.18e-041182HP:0000030
HumanPhenoVanishing testis

GATA4 MAP3K1

1.18e-041182HP:0012870
HumanPhenoOvarian gonadoblastoma

GATA4 MAP3K1

1.18e-041182HP:0000149
HumanPhenoTesticular dysgenesis

GATA4 MAP3K1

1.67e-041382HP:0008715
HumanPhenoHypoplasia of the vagina

GATA4 MAP3K1

2.56e-041682HP:0008726
HumanPhenoPrimary gonadal insufficiency

GATA4 MAP3K1

2.90e-041782HP:0008193
HumanPhenoFemale external genitalia in individual with 46,XY karyotype

GATA4 MAP3K1

2.90e-041782HP:0008730
HumanPhenoUrogenital sinus anomaly

GATA4 MAP3K1

3.26e-041882HP:0100779
HumanPhenoGonadoblastoma

GATA4 MAP3K1

3.26e-041882HP:0000150
HumanPhenoAbnormal sex determination

GATA4 MAP3K1

4.47e-042182HP:0012244
DomainGlycophorin

GYPA GYPB GYPE

1.21e-084283IPR001195
DomainGLYCOPHORIN_A

GYPA GYPB

2.17e-062282PS00312
DomainGlycophorin_CS

GYPA GYPB

2.17e-062282IPR018938
PathwayREACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC

MUC16 MUC5B

2.50e-0416212M27410
PathwayPID_SMAD2_3PATHWAY

NUP153 MAP3K1

2.50e-0416212M228
PathwayREACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS

MUC16 MUC5B

2.84e-0417212M27412
PathwayREACTOME_HEMOSTASIS

GATA4 SDC3 GYPA PDPK1 GYPB TUBAL3

3.56e-04679216M8395
PathwayBIOCARTA_RAC1_PATHWAY

TRIO MAP3K1

4.36e-0421212MM1463
PathwayBIOCARTA_RAC1_PATHWAY

TRIO MAP3K1

4.36e-0421212M8601
PathwayREACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS

MUC16 MUC5B

4.36e-0421212MM15706
PathwayREACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS

MUC16 MUC5B

5.25e-0423212M556
PathwayREACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION

GATA4 KIF28P TUBAL3

6.48e-04116213MM15715
PathwayREACTOME_DECTIN_2_FAMILY

MUC16 MUC5B

6.72e-0426212M27483
Pubmed

Isolation and pathogenic characterization of an OB1 variant of Babesia rodhaini which has a glycophorin A-independent pathway to murine red blood cells.

GYPA GYPB GYPE

5.21e-10329319084340
Pubmed

Characterization of glycophorin A transcripts: control by the common erythroid-specific promoter and alternative usage of different polyadenylation signals.

GYPA GYPB GYPE

5.21e-1032937798177
Pubmed

Full length mouse glycophorin gene constructed using recombinant polymerase chain reaction.

GYPA GYPB GYPE

5.21e-1032932043106
Pubmed

Rapidly evolving genes in human. I. The glycophorins and their possible role in evading malaria parasites.

GYPA GYPB GYPE

5.21e-10329312949139
Pubmed

Detailed physical mapping of the genes encoding glycophorins A, B and E, as revealed by P1 plasmids containing human genomic DNA.

GYPA GYPB GYPE

5.21e-1032937622054
Pubmed

Regulatory function of delta/YY-1 on the locus control region-like sequence of mouse glycophorin gene in erythroleukemia cells.

GYPA GYPB GYPE

5.21e-1032938662744
Pubmed

Isolation of the cDNA clone for mouse glycophorin, erythroid-specific membrane protein.

GYPA GYPB GYPE

5.21e-1032932753361
Pubmed

Structural variation of the malaria-associated human glycophorin A-B-E region.

GYPA GYPB GYPE

5.21e-10329332600246
Pubmed

Novel hybrid genes and a splice site mutation encoding the Sta antigen among Japanese blood donors.

GYPA GYPB GYPE

5.21e-10329332394466
Pubmed

Mechanism of protein sorting during erythroblast enucleation: role of cytoskeletal connectivity.

GYPA GYPB GYPE

5.21e-10329314563645
Pubmed

Glycophorin A requirement for expression of O-linked antigens on the erythrocyte membrane.

GYPA GYPB GYPE

2.08e-09429312940824
Pubmed

SCL assembles a multifactorial complex that determines glycophorin A expression.

GYPA GYPB GYPE

2.08e-09429314749362
Pubmed

Targeted erythropoietin selectively stimulates red blood cell expansion in vivo.

GYPA GYPB GYPE

2.08e-09429327114509
Pubmed

Interactions of mouse glycophorin A with the dRTA-related mutant G719D of the mouse Cl-/HCO3- exchanger Ae1.

GYPA GYPB GYPE

2.08e-09429321455273
Pubmed

Genetic control of blood parasitaemia in mouse malaria maps to chromosome 8.

GYPA GYPB GYPE

5.21e-0952939398835
Pubmed

Direct association of YY-1 with c-Myc and the E-box binding protein in regulation of glycophorin gene expression.

GYPA GYPB GYPE

5.21e-0952939747880
Pubmed

Complete deficiency of glycophorin A in red blood cells from mice with targeted inactivation of the band 3 (AE1) gene.

GYPA GYPB GYPE

5.21e-0952939490702
Pubmed

The monoclonal antibody TER-119 recognizes a molecule associated with glycophorin A and specifically marks the late stages of murine erythroid lineage.

GYPA GYPB GYPE

1.04e-08629310848813
Pubmed

Structural organization of the mouse glycophorin A gene.

GYPA GYPB GYPE

1.82e-0872937896738
Pubmed

Genetic mapping near the myd locus on mouse chromosome 8.

GYPA GYPB GYPE

2.91e-0882937613034
Pubmed

Erythroferrone contributes to iron mobilization for embryo erythropoiesis in iron-deficient mouse pregnancies.

GYPA GYPB GYPE

2.91e-08829336071577
Pubmed

EKLF and KLF2 have compensatory roles in embryonic beta-globin gene expression and primitive erythropoiesis.

GYPA GYPB GYPE

6.23e-081029317675555
Pubmed

KLF2 is essential for primitive erythropoiesis and regulates the human and murine embryonic beta-like globin genes in vivo.

GYPA GYPB GYPE

6.23e-081029315947087
Pubmed

The Poly(C) Binding Protein Pcbp2 and Its Retrotransposed Derivative Pcbp1 Are Independently Essential to Mouse Development.

GYPA GYPB GYPE

2.90e-071629326527618
Pubmed

Confirmation and dissection of QTL controlling resistance to malaria in mice.

GYPA GYPB GYPE

3.52e-071729315170228
Pubmed

Kruppel-like factor 1 (KLF1), KLF2, and Myc control a regulatory network essential for embryonic erythropoiesis.

GYPA GYPB GYPE

4.22e-071829322566683
Pubmed

Circulating primitive erythroblasts establish a functional, protein 4.1R-dependent cytoskeletal network prior to enucleating.

GYPA GYPB GYPE

4.22e-071829328701737
Pubmed

Transcription arrest relief by S-II/TFIIS during gene expression in erythroblast differentiation.

GYPA GYPB GYPE

5.01e-071929319210546
Pubmed

Isolation of cDNA clones for human erythrocyte membrane sialoglycoproteins alpha and delta.

GYPA GYPB

6.71e-0722923196288
Pubmed

Resistance to malaria through structural variation of red blood cell invasion receptors.

GYPA GYPB

6.71e-07229228522690
Pubmed

Molecular genetics of glycophorin MNS variants.

GYPA GYPB

6.71e-0722929269716
Pubmed

The genotypes of GYPA and GYPB carrying the MNSs antigens are not associated with cerebral malaria.

GYPA GYPB

6.71e-07229217372674
Pubmed

Molecular genetics of human erythrocyte MiIII and MiVI glycophorins. Use of a pseudoexon in construction of two delta-alpha-delta hybrid genes resulting in antigenic diversification.

GYPA GYPB

6.71e-0722922016325
Pubmed

Identification of a novel human glycophorin, glycophorin E, by isolation of genomic clones and complementary DNA clones utilizing polymerase chain reaction.

GYPB GYPE

6.71e-0722922295603
Pubmed

Gene conversion confined to a direct repeat of the acceptor splice site generates allelic diversity at human glycophorin (GYP) locus.

GYPA GYPB

6.71e-0722921737789
Pubmed

Molecular analysis of human glycophorin MiIX gene shows a silent segment transfer and untemplated mutation resulting from gene conversion via sequence repeats.

GYPA GYPE

6.71e-0722921421409
Pubmed

Characterization of alternatively spliced transcript variants of glycophorin A and glycophorin B genes in Chinese blood donors.

GYPA GYPB

6.71e-07229235138639
Pubmed

Characterization of GYP*Mur and novel GYP*Bun-like hybrids in Thai blood donors reveals a qualitatively altered s antigen.

GYPA GYPB

6.71e-07229232201961
Pubmed

Structural organization of glycophorin A and B genes: glycophorin B gene evolved by homologous recombination at Alu repeat sequences.

GYPA GYPB

6.71e-0722922734312
Pubmed

Identification of recombination events resulting in three hybrid genes encoding human MiV, MiV(J.L.), and Sta glycophorins.

GYPA GYPB

6.71e-0722922015404
Pubmed

Molecular cloning of a human glycophorin B cDNA: nucleotide sequence and genomic relationship to glycophorin A.

GYPA GYPB

6.71e-0722923477806
Pubmed

Exon skipping caused by DNA recombination that introduces a defective donor splice site into the human glycophorin A gene.

GYPA GYPB

6.71e-0722928444872
Pubmed

Glycophorin He(Sta) of the human red blood cell membrane is encoded by a complex hybrid gene resulting from two recombinational events.

GYPA GYPB

6.71e-0722928193374
Pubmed

MNSs blood group glycophorin variants in Taiwan: a genotype-serotype correlation study of 'Mi(a)' and St(a) with report of two new alleles for St(a).

GYPA GYPB

6.71e-07229224858913
Pubmed

Molecular basis for the human erythrocyte glycophorin specifying the Miltenberger class I (MiI) phenotype.

GYPA GYPB

6.71e-0722921611092
Pubmed

Molecular genetics of the glycophorin gene family, the antigens for MNSs blood groups: multiple gene rearrangements and modulation of splice site usage result in extensive diversification.

GYPA GYPB

6.71e-0722928535438
Pubmed

Differential Etv2 threshold requirement for endothelial and erythropoietic development.

GYPA GYPB GYPE

7.94e-072229335649376
Pubmed

Disruption of palladin leads to defects in definitive erythropoiesis by interfering with erythroblastic island formation in mouse fetal liver.

GYPA GYPB GYPE

1.18e-062529317431131
Pubmed

DUSP28 links regulation of Mucin 5B and Mucin 16 to migration and survival of AsPC-1 human pancreatic cancer cells.

MUC16 MUC5B

2.01e-06329227230679
Pubmed

ANKRD13a controls early cell-death checkpoint by interacting with RIP1 independent of NF-κB.

GYPA GYPB GYPE

6.75e-064429334839354
Pubmed

ADAMTS3 activity is mandatory for embryonic lymphangiogenesis and regulates placental angiogenesis.

GYPA GYPB GYPE

7.22e-064529326446156
Pubmed

Expression of Muc19/Smgc gene products during murine sublingual gland development: cytodifferentiation and maturation of salivary mucous cells.

MUC16 MUC5B

1.00e-05629219110483
Pubmed

Introduction of a real-time-based blood-group genotyping approach.

GYPA GYPB

1.87e-05829218510579
Pubmed

Architecture of the human erythrocyte ankyrin-1 complex.

GYPA GYPB

1.87e-05829235835865
Pubmed

Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.

MUC16 MUC5B

1.02e-041829218834073
Pubmed

Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains.

GATA4 NUP153

1.14e-041929214578343
Pubmed

Large-scale screen for genes controlling mammalian embryogenesis, using high-throughput gene expression analysis in mouse embryos.

GYPA GYPB GYPE

2.75e-0415229311044609
Pubmed

Insulin and IGF1 receptors are essential for XX and XY gonadal differentiation and adrenal development in mice.

GATA4 MAP3K1

3.70e-043429223300479
Pubmed

Akt1 signaling coordinates BMP signaling and β-catenin activity to regulate second heart field progenitor development.

GATA4 PDPK1

3.70e-043429225670795
Pubmed

WT1-mediated gene regulation in early urogenital ridge development.

GATA4 MUC16

6.50e-044529218391535
Pubmed

Spatiotemporal gene expression patterns reveal molecular relatedness between retinal laminae.

AP4E1 POU4F3

7.71e-044929231609468
Cytoband4q31.21

GYPA GYPB

1.24e-04262924q31.21
CytobandEnsembl 112 genes in cytogenetic band chr4q31

GYPA GYPB GYPE

1.53e-04164293chr4q31
GeneFamilyGlycosyltransferase family 6|Blood group antigens

GYPA GYPB GYPE

1.02e-0537213454
GeneFamilyCD molecules|Mucins

MUC16 MUC5B

2.66e-0421212648
GeneFamilyBlood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing

MYOT TRIO

1.48e-02161212593
CoexpressionXIE_ST_HSC_S1PR3_OE_DN

GYPA GYPB GYPE

2.12e-0623293M41756
CoexpressionWELCH_GATA1_TARGETS

GYPA GYPB GYPE

3.50e-0627293MM1144
CoexpressionDESCARTES_FETAL_SPLEEN_ERYTHROBLASTS

GYPA GYPB GYPE

5.56e-0567293M40294
CoexpressionTABULA_MURIS_SENIS_SPLEEN_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_CELL_AGEING

GYPA GYPB GYPE

7.19e-0573293MM3841
CoexpressionDESCARTES_FETAL_LIVER_ERYTHROBLASTS

GYPA GYPB GYPE

8.76e-0578293M40235
CoexpressionRAMALHO_STEMNESS_DN

GYPA GYPB GYPE

8.76e-0578293MM1015
CoexpressionSARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP

RGL1 FRMD6

1.79e-0418292M1633
CoexpressionDING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER

PHC3 NUP153 MAP3K1

1.83e-04100293M14670
CoexpressionDESCARTES_FETAL_STOMACH_ERYTHROBLASTS

GYPA GYPB GYPE

1.89e-04101293M40297
CoexpressionHE_LIM_SUN_FETAL_LUNG_C3_DEFINITIVE_RETICULOCYTE

GYPA GYPB GYPE

2.49e-04111293M45750
CoexpressionTABULA_MURIS_SENIS_MARROW_GRANULOCYTOPOIETIC_CELL_AGEING

GYPA GYPB GYPE

2.49e-04111293MM3798
CoexpressionHE_LIM_SUN_FETAL_LUNG_C3_PRIMITIVE_ERYTHROCYTE

GYPA GYPB GYPE

2.70e-04114293M45759
CoexpressionDESCARTES_FETAL_ADRENAL_ERYTHROBLASTS

GYPA GYPB GYPE

2.91e-04117293M40150
CoexpressionSARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP

RGL1 FRMD6

2.95e-0423292MM1198
CoexpressionKORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN

FRMD6 CPEB1

3.49e-0425292M15380
CoexpressionVALK_AML_CLUSTER_8

GYPA GYPB

3.49e-0425292M6241
CoexpressionIVANOVA_HEMATOPOIESIS_MATURE_CELL

RAB11FIP4 GYPA GYPB GYPE

3.93e-04317294MM1163
CoexpressionDESCARTES_FETAL_MUSCLE_ERYTHROBLASTS

GYPA GYPB GYPE

4.05e-04131293M40253
CoexpressionHE_LIM_SUN_FETAL_LUNG_C3_DEFINITIVE_ERYTHROCYTE

GYPA GYPB

4.39e-0428292M45749
CoexpressionDESCARTES_FETAL_PANCREAS_ERYTHROBLASTS

GYPA GYPB GYPE

4.72e-04138293M40261
CoexpressionNABA_MATRISOME_METASTATIC_COLORECTAL_LIVER_METASTASIS

MUC16 FNDC1

5.04e-0430292M47990
CoexpressionJOHNSTONE_PARVB_TARGETS_2_DN

PHC3 CHML FRMD6 NUP153

5.34e-04344294M2239
ToppCell10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-eosinophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

NMUR1 GYPA GYPB GYPE

4.55e-061722943a76cfb2832790144a6da6406469ead0767916b5
ToppCellTracheal-10x5prime-Hematologic-Erythrocyte-Erythrocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

NMUR1 GYPA GYPB

3.30e-0596293c3ac1626a3f3931784605f95db1fcdec2c8ad62e
ToppCellTracheal-10x5prime-Hematologic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

NMUR1 GYPA GYPB

3.30e-05962935bd480030df9a4cb8c3b4b6ceee20981fbd67baf
ToppCellTracheal-10x5prime-Hematologic-Erythrocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

NMUR1 GYPA GYPB

3.30e-059629374521ab61413f17a9858d3ea4ea63999459aafbc
ToppCellTCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Non-Seminoma-_Choriocarcinoma,_Embryonal_Carcinoma,_Immature_Teratoma,_Mature_Teratoma,_Yolk_Sac_Tumor|TCGA-Testes / Sample_Type by Project: Shred V9

GYPA GYPB GYPE

3.41e-05972930f31f58ed031183726b7ad8f9133b50ca1bb1a9a
ToppCellCOVID-19_Mild-Hematopoietic_R|COVID-19_Mild / Disease group, lineage and cell class

GYPA GYPB GYPE

6.43e-0512029335f06e5758f404e94d650e69242e5f44f28816b4
ToppCellCOVID-19_Mild-Hematopoietic_R-RBC|COVID-19_Mild / Disease group, lineage and cell class

GYPA GYPB GYPE

6.43e-05120293fd500a0034516a83d374d5df03338be6154a4f96
ToppCell(2)_unknow|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)

GYPA GYPB GYPE

6.59e-051212930090aef3d8a42968828edc637773ef99b2940dde
ToppCell(2)_Unknown|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)

GYPA GYPB GYPE

6.59e-051212936689c9016f29ce6a16824614b6229a71c42babb5
ToppCellPBMC-Mild-Hematopoietic-RBC-RBC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

GYPA GYPB GYPE

6.92e-05123293cc26155c55e400a0219c5f7f8217aa9c3c912e4e
ToppCellPBMC-Mild-Hematopoietic-RBC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

GYPA GYPB GYPE

6.92e-051232937cccdc84130452fa48de47603ab1cc785a0a8c1a
ToppCellPBMC-Mild-Hematopoietic-RBC-RBC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

GYPA GYPB GYPE

6.92e-051232939649daf3af2ba6fda4b14925ed03e469496b7a7b
ToppCellPBMC-Mild-Hematopoietic-RBC-RBC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

GYPA GYPB GYPE

6.92e-05123293253e401bc546574e0c4a443b3082fb53b4d5ef60
ToppCellPBMC-Mild-Hematopoietic-RBC-RBC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

GYPA GYPB GYPE

6.92e-051232938ad6bca3053d1d001f8c34a58374f14c224bf2e7
ToppCellPBMC-Mild-Hematopoietic-RBC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

GYPA GYPB GYPE

6.92e-051232934960a126a878791c6bd190d030a9fecd164e9a24
ToppCellMegakaryocytic-erythropoietic-Erythro-cells-Erythrocyte|Erythro-cells / Lineage, cell class and subclass

GYPA GYPB GYPE

1.10e-041442937fbedc65314cfb06bcc527d794b5de7858f7c5ec
ToppCell368C-Lymphocytic-NK_cells|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

NMUR1 GYPB GYPE

1.25e-0415029317b3ac5ddc47b9cba0a27b268d63a6e491b2b111
ToppCellHealthy_donor-RBC|World / disease group, cell group and cell class (v2)

SPRY3 GYPA GYPB

1.25e-041502931e1a497ec4b048f7e9cc12dd5dd9aba7fedca9e1
ToppCellCOVID-19-lung-Mesothelial|lung / Disease (COVID-19 only), tissue and cell type

GATA4 MUC16 CPEB1

1.40e-04156293e1f563869b3bf997eaa2e756e31b53db1a478903
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

NMUR1 FNDC1 FRMD6

1.53e-04161293a7e09cf2ca6cd70d40d08440fe9c5ab9befa1b79
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

NMUR1 FNDC1 FRMD6

1.53e-0416129308920a716f6ec62538e361211455a30ad726d7be
ToppCellSmart-seq2-tissue-resident_(Smart-seq2)-hematologic-erythrocytic-erythrocyte|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

GYPA GYPB GYPE

1.56e-0416229325a11e4c6304324310b33a33331ebc812d045d4a
ToppCell11.5-Distal-RBC|Distal / Age, Tissue, Lineage and Cell class

GYPA GYPB GYPE

1.59e-04163293e9d814952d824539ff1dea119e4fca14a8c335a8
ToppCell11.5-Distal-RBC-RBC|Distal / Age, Tissue, Lineage and Cell class

GYPA GYPB GYPE

1.59e-0416329331b60e065bac4ad380247964e7574f210106ebae
ToppCellTCGA-Thymus-Primary_Tumor-Thymoma-Type_C|TCGA-Thymus / Sample_Type by Project: Shred V9

MUC16 FNDC1 RAB11FIP4

1.59e-041632932dac87d15051151ccf193760ddd8b82534c3f922
ToppCelldroplet-Marrow-BM-30m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SDC3 RGL1 FNDC1

1.62e-04164293758e85e2f5e7236b345e16c78344d5e0bf17d8dc
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3_LINC00507_PSRC1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

GYPA GYPB GYPE

1.65e-041652936de69b75174731931e7e80a3488f983a7ba4defe
ToppCell11.5-Airway-RBC-RBC|Airway / Age, Tissue, Lineage and Cell class

GYPA GYPB GYPE

1.65e-041652938618b2c5659aa70c7c9d6e51a227ac612b4ad17b
ToppCell11.5-Airway-RBC|Airway / Age, Tissue, Lineage and Cell class

GYPA GYPB GYPE

1.65e-0416529346042340a373adaf1c439b2301e02fbae3e31a4f
ToppCellTCGA-Lung-Solid_Tissue_Normal|TCGA-Lung / Sample_Type by Project: Shred V9

NMUR1 C10orf67 GYPE

1.68e-04166293a8ebdd3cb7f59b3feeaacda45ce6d40d10db556f
ToppCellTCGA-Lung-Solid_Tissue_Normal-Lung|TCGA-Lung / Sample_Type by Project: Shred V9

NMUR1 C10orf67 GYPE

1.68e-04166293c64971c27cb445dffc5a636d4b6a60261b93a2db
ToppCellTCGA-Lung-Solid_Tissue_Normal-Lung-Lung_normal_tissue-6|TCGA-Lung / Sample_Type by Project: Shred V9

NMUR1 C10orf67 GYPE

1.68e-04166293188f2575511f418216874aed9118aa6f165252cb
ToppCellTCGA-Lung-Solid_Tissue_Normal-Lung-Lung_normal_tissue|TCGA-Lung / Sample_Type by Project: Shred V9

NMUR1 C10orf67 GYPE

1.68e-041662932f3072a7af048f184d33065fdd36153fd563155a
ToppCellmild_COVID-19-HSPC|mild_COVID-19 / disease group, cell group and cell class (v2)

GYPA GYPB CPEB1

1.74e-0416829390b33962adb77d8326dee403712118398b4d1315
ToppCell10x_3'_v3-lymph_node_(10x_3'_v3)-hematologic-erythrocytic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

GYPA GYPB GYPE

1.74e-04168293360cd756067c8cfb6a78301674758eb5fac52c23
ToppCell10x_3'_v3-lymph_node_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

GYPA GYPB GYPE

1.74e-04168293d791116040a9d3ea0485d68c974340116073986b
ToppCell10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic-erythroid_lineage_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

GYPA GYPB GYPE

1.80e-04170293288014dedda8babc51fe08e48a55e68d83e1b1d2
ToppCell10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-hematopoietic_progenitor-erythroid_progenitor_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

GYPA GYPB GYPE

1.80e-0417029374bb46826141bd1e80b4ce16e6bbfc770bd427d3
ToppCell10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-hematopoietic_progenitor|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

GYPA GYPB GYPE

1.80e-041702936592ebe204b43b81c6b6da99e05da72c0983b3fa
ToppCellCOVID-19-lung-RBC|lung / Disease (COVID-19 only), tissue and cell type

GYPA GYPB GYPE

1.83e-041712930e8d63c8fbccdda4f1ef00de00667a50464b104b
ToppCell3'-GW_trimst-1-LargeIntestine-Hematopoietic-Red_blood_cells-RBC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GYPA GYPB GYPE

1.83e-04171293f21eae4dd2e0a566eff792d19367e96ffb0b74ba
ToppCell3'-GW_trimst-1-LargeIntestine-Hematopoietic-Red_blood_cells|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GYPA GYPB GYPE

1.83e-04171293d428c2859a1efc284610ca241a6dae9f182309cd
ToppCell5'-GW_trimst-2-LargeIntestine-Hematopoietic-Red_blood_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GYPA GYPB GYPE

1.86e-04172293cc1a45a35f78063b2a777ae905f70f894fbcb22f
ToppCellwk_20-22-Hematologic-Meg-ery-Definitive_erythrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

GYPA GYPB GYPE

1.86e-04172293f0b658baa4b41329c95a09387cc55ea046e2333f
ToppCell5'-GW_trimst-2-LargeIntestine-Hematopoietic-Red_blood_cells-RBC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GYPA GYPB GYPE

1.86e-0417229330c57f5ca2326e8d890d9aac8096c64e5b51a24f
ToppCell5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Red_blood_cells|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GYPA GYPB GYPE

1.86e-041722938ccc3459dbdf103c631aa2a0defb8790c06ad6c1
ToppCell5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Red_blood_cells-RBC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GYPA GYPB GYPE

1.86e-04172293acdc261001f63a8cfce1216ef1e33b4e034b1c11
ToppCell5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Red_blood_cells-RBC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GYPA GYPB GYPE

1.93e-04174293ce2bc1797707c3f48ef551de7edbfd7b47e5a36e
ToppCell5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Red_blood_cells|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GYPA GYPB GYPE

1.93e-04174293001254db9f4c346d06d31a7fa1213498f92e4280
ToppCellCOVID-19-lung-RBC|COVID-19 / Disease (COVID-19 only), tissue and cell type

GYPA GYPB GYPE

1.96e-041752934c35292ad2ac712ba7516f27dd6eac6ba8fdd163
ToppCellwk_15-18-Hematologic-Meg-ery-Definitive_erythrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

GYPA GYPB GYPE

2.00e-041762939af82b976e6a14a3ef7aa50f1f7af2463e5aa5d2
ToppCell3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC16 MUC5B C10orf67

2.00e-04176293dee780cfa85234a7cd7bf440b66b84cec959893e
ToppCellwk_20-22-Hematologic-Meg-ery-Cycling_definitive_erythroblast|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

GYPA GYPB GYPE

2.00e-0417629398814f0a67411b2f7b25dc489b2aadb77f45a853
ToppCellwk_15-18-Hematologic-Meg-ery-Primitive_erythrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

GYPA GYPB GYPE

2.00e-04176293664a7d15563428d0ae156d97aa88415fd0a0506a
ToppCellHealthy-RBC|World / disease group, cell group and cell class

GYPA GYPB GYPE

2.03e-041772932ce41e37fa7139c7bd2b464bd86c5601dc501515
ToppCellHealthy-RBC|Healthy / disease group, cell group and cell class

GYPA GYPB GYPE

2.03e-04177293945d72ab52efa9a9468daace9f9ec676a891d963
ToppCell10x_3'_v3-thymus_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

GYPA GYPB GYPE

2.10e-04179293dfefa4b7ae0ee50cf67e0f1938c682f08a03ec53
ToppCell10x_3'_v3-thymus_(10x_3'_v3)-hematologic-erythrocytic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

GYPA GYPB GYPE

2.10e-0417929364672528f73ac0921f9c7df72e14ecbfac4d5270
ToppCellCOVID-19_Moderate-RBC|World / disease group, cell group and cell class

GYPA GYPB GYPE

2.10e-04179293932fa98c0981ef8ef1e4945cdd4ae8c6c0858251
ToppCell10x_3'_v3-thymus_(10x_3'_v3)-hematologic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

GYPA GYPB GYPE

2.10e-04179293fa0dd87111d399649cdea55f2e610ebc169e8a56
ToppCellwk_08-11-Hematologic-Meg-ery-Primitive_erythrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

GYPA GYPB GYPE

2.10e-041792933c8046f43da5a02fa4278a7175b9cd8cf95b8e27
ToppCellMultiple_Sclerosis-Other-RBC|Multiple_Sclerosis / Disease, Lineage and Cell Type

GYPA GYPB GYPE

2.10e-0417929315763dc59ee6186416e203ffbb450ae4608eba59
ToppCell18-Airway-RBC|Airway / Age, Tissue, Lineage and Cell class

GYPA GYPB GYPE

2.13e-0418029335bf5f35cf346a5b27f5e819b77db34130d70db1
ToppCell18-Airway-RBC-RBC|Airway / Age, Tissue, Lineage and Cell class

GYPA GYPB GYPE

2.13e-041802933b4b220a3c150426ae55239baff756f1a7f1e1d7
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Hematopoietic-Megakaryocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

GYPA GYPB GYPE

2.17e-0418129314c2dd946e89ba578711c2d25935b6b3d319b701
ToppCellwk_20-22-Hematologic-Meg-ery|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

GYPA GYPB GYPE

2.17e-04181293d0637f9ccec5dba4997520b27287989522e04f96
ToppCell5'-GW_trimst-2-LymphNode-Hematopoietic-Red_blood_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GYPA GYPB GYPE

2.17e-04181293577bf37a6594fad01251d2c66d8ccda8e949b6cf
ToppCell5'-GW_trimst-2-LymphNode-Hematopoietic-Red_blood_cells-RBC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GYPA GYPB GYPE

2.17e-04181293f5dc7a650afe8837cb424981e50ad2c8b18c7c32
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Hematopoietic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

GYPA GYPB GYPE

2.17e-041812939dc0563453e24c9d1d975e2e0e1e272487e19908
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-Mast-Mast-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

GYPA GYPB GYPE

2.17e-04181293c35ca98c474e31917e0a53c092397e0d8d18b37c
ToppCell3'-GW_trimst-2-SmallIntestine-Hematopoietic-Red_blood_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GYPA GYPB GYPE

2.17e-04181293fe2f8b4bd8b09be8ba933529a16e1dca08740dab
ToppCell3'-GW_trimst-1-SmallIntestine-Hematopoietic-Red_blood_cells-RBC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GYPA GYPB GYPE

2.17e-04181293f4cd6dba4c04c5cb550f44468eb29c07238fbda4
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

GYPA GYPB GYPE

2.17e-04181293c5843b89f3d362e236ff76c3279518a2fdfc1f75
ToppCell3'-GW_trimst-1-SmallIntestine-Hematopoietic-Red_blood_cells|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GYPA GYPB GYPE

2.17e-04181293c7f5d0e5aa2ca6a409957713637e1b37a73ceb60
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

GYPA GYPB GYPE

2.17e-04181293fcefb5902416c004631f4f8dd5c8f99fe3bd90bc
ToppCell3'-GW_trimst-2-SmallIntestine-Hematopoietic-Red_blood_cells-RBC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GYPA GYPB GYPE

2.17e-04181293a16079b1c832456b974d9d06dd1a3eda63ac1bce
ToppCellwk_15-18-Hematologic-Meg-ery-Definitive_erythroblast|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

GYPA GYPB GYPE

2.20e-0418229393841f730ca1a735eaaf5f2ccbe5c45ab0e029d1
ToppCellFetal_29-31_weeks-Immune-enucleated_erythrocyte-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

GYPA GYPB GYPE

2.20e-04182293a99d48084aa6f5c34f4a622ae6c2165db7f0beff
ToppCellwk_15-18-Hematologic-Meg-ery|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

GYPA GYPB GYPE

2.20e-041822931adb8d6404d50155e9f9ba805abef63929fe865f
ToppCellfacs-Heart-LV-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SDC3 POC5 MAP3K1

2.20e-041822936dff753d65ba45db81f3cc0c9f59e1779d490955
ToppCell10x_3'_v3-spleen_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

GYPA GYPB GYPE

2.24e-04183293b52d7683dc6652766e814ebe935c264ecd610c4b
ToppCell10x_3'_v3-spleen_(10x_3'_v3)-hematologic|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

GYPA GYPB GYPE

2.24e-041832931db466cf757813322db1cdcc0bf1d91c062fd9de
ToppCell10x_3'_v3-spleen_(10x_3'_v3)-hematologic-erythrocytic|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

GYPA GYPB GYPE

2.24e-041832931d77d8d8c8f78f43dd8864e76f294ee66d4942c2
ToppCellControl-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations)

GATA4 MUC16 MUC5B

2.24e-0418329315d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2
ToppCellwk_15-18-Hematologic-Meg-ery-Definitive_reticulocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

GYPA GYPB GYPE

2.24e-041832935470e5ac3439cfc96acd2202f6b1e386779a6637
ToppCellCOVID-19_Moderate-RBC|COVID-19_Moderate / disease group, cell group and cell class

GYPA GYPB GYPE

2.24e-041832930dc337cd3f4f7964b0a268139c7ddc0f58b6a279
ToppCellwk_08-11-Hematologic-Meg-ery|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

GYPA GYPB GYPE

2.24e-041832937eecb8d80e31ca26c2e6ce43bf0f2c71be1643e4
ToppCell10x5'v1-week_17-19-Hematopoietic-erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

GYPA GYPB GYPE

2.27e-041842930efc757d9512d6a8fe8176e977a94e4494ed9778
ToppCellwk_15-18-Hematologic-Meg-ery-Cycling_definitive_erythroblast|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

GYPA GYPB GYPE

2.27e-04184293238eba615b4e04967d44ac7858a6673bdd7f67e9
ToppCellCOVID-19_Severe-RBC|COVID-19_Severe / disease group, cell group and cell class

GYPA GYPB GYPE

2.27e-04184293bb58244194ffb5558fbe85c5f856888210dcb1e8
ToppCellPBMC-Severe-Hematopoietic-RBC-RBC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

GYPA GYPB GYPE

2.31e-0418529317542ccd52a821c9e99b1a7469e80502e764b3fd
ToppCellPBMC-Severe-Hematopoietic-RBC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

GYPA GYPB GYPE

2.31e-04185293d685a5a2e525db2eba449cfa1e5cd54eb36162a8
ToppCellFetal_29-31_weeks-Immune-enucleated_erythrocyte-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

GYPA GYPB GYPE

2.31e-04185293c4bf3ac684c1a8876b51f7af4d3a62dc47e961ee
ToppCellPBMC-Severe-Hematopoietic-RBC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

GYPA GYPB GYPE

2.31e-041852935d8d6fd7800f76ee3aa5cef95241d8e6d7e8db04
ToppCellPBMC-Severe-Hematopoietic-RBC-RBC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

GYPA GYPB GYPE

2.31e-04185293100b5afdf3c6ab07ffc493f7883f5a7b31c59184
ToppCellCOVID-19_Severe-Hematopoietic_R|COVID-19_Severe / Disease group, lineage and cell class

GYPA GYPB GYPE

2.31e-0418529330f064ab7c3890e6f419a845276b145112e78f52
ToppCellFetal_29-31_weeks-Immune-enucleated_erythrocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

GYPA GYPB GYPE

2.31e-04185293e8f7da9641b6cf1db1093b4f301ce828fd3a529c
ToppCellwk_20-22-Hematologic-Meg-ery-Definitive_reticulocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

GYPA GYPB GYPE

2.31e-041852934a2c85e292d4cbce80e92992ded5d66a3aa446ee
ToppCellPBMC-Severe-Hematopoietic-RBC-RBC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

GYPA GYPB GYPE

2.31e-04185293f3b1907c3b6f930bc161f46efce5e143babab507
ToppCellPBMC-Severe-Hematopoietic-RBC-RBC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

GYPA GYPB GYPE

2.31e-0418529344ce50cb99df8ffc50eba311adcf688477618659
ComputationalGenes in the cancer module 539.

GYPA GYPB GYPE

2.58e-0616193MODULE_539
ComputationalNeighborhood of PCAF

GYPA GYPB GYPE

3.22e-0536193GNF2_PCAF
ComputationalNeighborhood of CDC27

GYPA GYPB GYPE

1.50e-0460193GNF2_CDC27
ComputationalNeighborhood of BNIP3L

GYPA GYPB GYPE

2.18e-0468193GNF2_BNIP3L
ComputationalNeighborhood of RAD23A

GYPA GYPB GYPE

2.28e-0469193GNF2_RAD23A
ComputationalNeighborhood of TAL1

GYPA GYPB GYPE

2.69e-0473193GNF2_TAL1
ComputationalNeighborhood of ANK1

GYPA GYPB GYPE

2.80e-0474193GNF2_ANK1
ComputationalNeighborhood of SPTB

GYPA GYPB GYPE

2.80e-0474193GNF2_SPTB
ComputationalNeighborhood of MAP2K3

GYPA GYPB GYPE

2.92e-0475193GNF2_MAP2K3
ComputationalNeighborhood of SPTA1

GYPA GYPB GYPE

3.66e-0481193GNF2_SPTA1
ComputationalGenes upregulated in subsets of cells of a given type within various tumors

TRIO MAP3K1

3.45e-0350192GAVISH_3CA_MALIGNANT_METAPROGRAM_29_NPC_OPC
DrugLi Bo

GYPA GYPE

9.38e-064292CID006327674
DrugDdpc

GYPA GYPE

1.56e-055292CID000130969
DrugBerol

GYPA GYPE

2.34e-056292CID000069182
DrugYsdspstst

GYPA GYPE

8.55e-0511292CID003083137
DrugOxamniquine [21738-42-1]; Down 200; 14.4uM; MCF7; HT_HG-U133A

RGL1 TRIO GRPR MAP3K1

9.67e-051912944124_DN
Drug5707885; Down 200; 50uM; PC3; HT_HG-U133A

PHC3 CHML GRPR GYPA

9.87e-051922946438_DN
DrugPrednicarbate [73771-04-7]; Up 200; 8.2uM; MCF7; HT_HG-U133A

SDC3 CHML TRIO MAP3K1

1.05e-041952943542_UP
DrugPropylthiouracil [51-52-5]; Up 200; 23.4uM; MCF7; HT_HG-U133A

AP4E1 PHC3 TRIO MAP3K1

1.07e-041962942837_UP
DrugTamoxifen citrate [54965-24-1]; Down 200; 7uM; MCF7; HT_HG-U133A

GATA4 AP4E1 SDC3 PHC3

1.09e-041972946768_DN
Drugalpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A

GATA4 SDC3 RGL1 PHC3

1.09e-041972945207_UP
DrugProchlorperazine dimaleate [84-02-6]; Up 200; 6.6uM; PC3; HT_HG-U133A

AP4E1 NMUR1 PHC3 MAP3K1

1.09e-041972946664_UP
DrugDenatonium benzoate [3734-33-6]; Down 200; 9uM; MCF7; HT_HG-U133A

GATA4 SDC3 GRPR MAP3K1

1.11e-041982946502_DN
DrugDichlorphenamide [120-97-8]; Up 200; 13.2uM; HL60; HT_HG-U133A

AP4E1 NMUR1 GRPR GYPA

1.11e-041982943027_UP
Drugretinoic acid; Down 200; 1uM; MCF7; HG-U133A

RGL1 TRIO GRPR GYPB

1.13e-04199294384_DN
Diseasediabetic neuropathy

GYPA GYPB GYPE

8.52e-095293EFO_1000783
Diseasechronic bronchitis

GYPA GYPB GYPE

1.40e-0711293EFO_0006505
Diseaseresponse to beta blocker, heart rate

RGL1 GYPA GYPB GYPE

2.87e-0757294EFO_0004326, EFO_0007766
Diseasecognitive behavioural therapy

POU4F3 GYPA GYPB GYPE

3.08e-0758294EFO_0007820
Diseasesusceptibility to cold sores measurement

MUC16 GYPA GYPB GYPE

4.89e-0765294EFO_0008402
Diseasekidney volume

GYPA GYPB GYPE

6.90e-0718293EFO_0600044
Diseaseemphysema pattern measurement

GYPA GYPB GYPE

8.18e-0719293EFO_0005850
Diseasegas trapping measurement

GYPA GYPB GYPE

3.07e-0629293EFO_0007628
Diseaseresting heart rate, chronic obstructive pulmonary disease

GYPA GYPB GYPE

3.40e-0630293EFO_0000341, EFO_0004351
Diseaseblood pressure, chronic obstructive pulmonary disease

GYPA GYPB GYPE

4.15e-0632293EFO_0000341, EFO_0004325
Diseasepack-years measurement, systolic blood pressure

GYPA GYPB GYPE

5.00e-0634293EFO_0006335, EFO_0006526
Diseaseessential tremor

TRIO GYPA GYPB GYPE

9.38e-06136294EFO_0003108
Diseasehip geometry

GYPA GYPB GYPE

1.10e-0544293EFO_0004685
Diseaseornithine measurement

GYPA GYPB GYPE

1.10e-0544293EFO_0009776
Diseasecryptic phenotype measurement

GYPA GYPB GYPE

1.34e-0547293EFO_0021487
Diseasepulmonary function measurement, smoking behaviour measurement, FEV/FEC ratio

GYPA GYPB GYPE

1.34e-0547293EFO_0003892, EFO_0004713, EFO_0005671
Diseaseprotein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2 measurement

GYPB GYPE

1.40e-056292EFO_0801956
Diseaseunipolar depression, sex interaction measurement

GYPA GYPB GYPE

1.72e-0551293EFO_0003761, EFO_0008343
Diseasepulmonary function measurement, FEV/FEC ratio

GYPA GYPB GYPE

1.93e-0553293EFO_0003892, EFO_0004713
Diseasebipolar disorder, body mass index

GYPA GYPB GYPE

4.86e-0572293EFO_0004340, MONDO_0004985
Disease46,XY partial gonadal dysgenesis

GATA4 MAP3K1

5.10e-0511292C4510744
Diseasepulmonary function measurement

GYPA GYPB GYPE

5.95e-0577293EFO_0003892
Diseasecardiac troponin I change measurement

GYPB GYPE

7.23e-0513292EFO_0600077
Diseasesmoking status measurement, chronic obstructive pulmonary disease

GYPA GYPB GYPE

8.85e-0588293EFO_0000341, EFO_0006527
Diseasetotal cortical area measurement

GYPA GYPB GYPE

1.08e-0494293EFO_0008381
Disease–

GYPA GYPB

1.11e-0416292611162
DiseaseMalaria, susceptibility to

GYPA GYPB

1.11e-0416292cv:C1970028
DiseaseMalaria

GYPA GYPB

1.75e-0420292C0024530
Diseasedaytime rest measurement

GYPA GYPB GYPE CPEB1

1.91e-04295294EFO_0007828
Diseasemalaria (is_implicated_in)

GYPA GYPB

2.54e-0424292DOID:12365 (is_implicated_in)
Diseasefemoral neck bone mineral density

GYPA GYPB GYPE

9.29e-04196293EFO_0007785
Diseasecortical surface area measurement, neuroimaging measurement

GYPA GYPB GYPE

1.42e-03227293EFO_0004346, EFO_0010736
Diseaseobsolete_red blood cell distribution width

SPRY3 POU4F3 GYPA GYPB GYPE MAP3K1

1.72e-031347296EFO_0005192
Diseasecholangiocarcinoma (is_marker_for)

MUC16 MUC5B

1.81e-0364292DOID:4947 (is_marker_for)
Diseaseerythrocyte measurement

GYPA GYPB GYPE

2.02e-03257293EFO_0005047
Diseasereticulocyte count

RGL1 GYPA GYPB GYPE MAP3K1

3.23e-031045295EFO_0007986
Diseasereticulocyte measurement

RGL1 GYPA GYPB GYPE MAP3K1

3.34e-031053295EFO_0010700

Protein segments in the cluster

PeptideGeneStartEntry
ETTSTHNMTCSSFSS

AP4E1

806

Q9UPM8
TTHTSTVLTTTATMT

MUC5B

4786

Q9HC84
HSIAMTSESSCTTID

CHML

341

P26374
ESSSSCSSIHSMDTN

RGL1

586

Q9NZL6
MTTSDLSTHSTTSLI

RAB11FIP4

196

Q86YS3
STMHTTSFLASSTEL

MUC16

3611

Q8WXI7
TLDTSSTTSLTMTHS

MUC16

7921

Q8WXI7
STTSLTMTHSTISQG

MUC16

7926

Q8WXI7
ASMTSTRAASASSVH

POC5

436

Q8NA72
SHSLSRMTTGSTLCD

NMUR1

386

Q9HB89
STTGVAMHTSTSSSV

GYPE

21

P15421
AATTRSNSTSMHSSI

PHC3

671

Q8NDX5
SQISTSTMTVTHNSS

TMEM123

126

Q8N131
STMTVTHNSSVTSAA

TMEM123

131

Q8N131
VTSAASSVTITTTMH

TMEM123

141

Q8N131
HSSSVSQTFSVSAMS

GATA4

376

P43694
LKTCSSMTSHGSSHT

FRMD6

421

Q96NE9
STTEVAMHTSTSSSV

GYPB

21

P06028
STMSSSVSSHLSSRT

FNDC1

761

Q4ZHG4
IRSHSTGRSTTCMTS

GRPR

346

P30550
STTGVAMHTSTSSSV

GYPA

21

P02724
SDSSAQSSTHSVLSM

CPEB1

116

Q9BZB8
ATTVSTTMATTAATS

SDC3

156

O75056
SKCVISMHSRTTTTT

KIF28P

26

B7ZC32
FVSRMSNSHTLSSSS

MAP3K1

411

Q13233
MQVSSSSSSHSLSAS

PDPK1

386

O15530
LTTHSTTEHTDCTFM

TUBAL3

196

A6NHL2
HTMSSVPCTSTSSTV

POU4F3

81

Q15319
QSSIASSMSHSTTAS

SPRY3

81

O43610
VQSRTTMTAISSSSH

C10orf67

486

Q8IYJ2
TMTAISSSSHCTSSI

C10orf67

491

Q8IYJ2
SAETMTASSSSCTVT

NUP153

766

P49790
ESSSSSNISTMLVTH

TRIO

2546

O75962
RFSASSTLSSHITMS

MYOT

51

Q9UBF9